|
|
Article: Chiron Spins Powder Injection Technology Into PowderMed Ltd.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BioWorld International Correspondent
LONDON - Chiron Corp. is spinning out the DNA vaccines technology it acquired when it took over PowderJect Pharmaceuticals plc to a team of former PowderJect managers.
The new company, PowderMed Ltd., raised [pounds sterling]20 million (US$34.5 million) in a private financing and will inherit a long-standing collaboration with GlaxoSmithKline plc, of London. PowderMed has rights to develop vaccines delivered by the needle-free powder injection technology around which PowderJect was formed, and the company starts its independent life with a portfolio of five preclinical DNA vaccines. The first, for lung cancer, is due ...